57 related articles for article (PubMed ID: 26117056)
21. Small molecule inhibitors of WNT signaling effectively induce apoptosis in acute myeloid leukemia cells.
Minke KS; Staib P; Puetter A; Gehrke I; Gandhirajan RK; Schlösser A; Schmitt EK; Hallek M; Kreuzer KA
Eur J Haematol; 2009 Mar; 82(3):165-75. PubMed ID: 19067737
[TBL] [Abstract][Full Text] [Related]
22. Differentiation-inducing factor-1 alters canonical Wnt signaling and suppresses alkaline phosphatase expression in osteoblast-like cell lines.
Matsuzaki E; Takahashi-Yanaga F; Miwa Y; Hirata M; Watanabe Y; Sato N; Morimoto S; Hirofuji T; Maeda K; Sasaguri T
J Bone Miner Res; 2006 Aug; 21(8):1307-16. PubMed ID: 16869729
[TBL] [Abstract][Full Text] [Related]
23. Beta-catenin/LEF1 activated enamelin expression in ameloblast-like cells.
Tian H; Lv P; Ma K; Zhou C; Gao X
Biochem Biophys Res Commun; 2010 Jul; 398(3):519-24. PubMed ID: 20599763
[TBL] [Abstract][Full Text] [Related]
24. Defining BMP functions in the hair follicle by conditional ablation of BMP receptor IA.
Kobielak K; Pasolli HA; Alonso L; Polak L; Fuchs E
J Cell Biol; 2003 Nov; 163(3):609-23. PubMed ID: 14610062
[TBL] [Abstract][Full Text] [Related]
25. Transcriptional regulation of MMP13 by Lef1 in chondrocytes.
Yun K; Im SH
Biochem Biophys Res Commun; 2007 Dec; 364(4):1009-14. PubMed ID: 17971297
[TBL] [Abstract][Full Text] [Related]
26. beta-Catenin/TCF/LEF1 can directly regulate phenylephrine-induced cell hypertrophy and Anf transcription in cardiomyocytes.
Zhang CG; Jia ZQ; Li BH; Zhang H; Liu YN; Chen P; Ma KT; Zhou CY
Biochem Biophys Res Commun; 2009 Dec; 390(2):258-62. PubMed ID: 19799869
[TBL] [Abstract][Full Text] [Related]
27. Methylprednisolone suppresses the Wnt signaling pathway in chronic lymphocytic leukemia cell line MEC-1 regulated by LEF-1 expression.
Yao QM; Li PP; Liang SM; Lu K; Zhu XJ; Liu YX; Zhang F; Yuan T; Wang X
Int J Clin Exp Pathol; 2015; 8(7):7921-8. PubMed ID: 26339357
[TBL] [Abstract][Full Text] [Related]
28. Alterations in WNT Signaling in Leukemias.
Fetisov TI; Lesovaya EA; Yakubovskaya MG; Kirsanov KI; Belitsky GA
Biochemistry (Mosc); 2018 Dec; 83(12):1448-1458. PubMed ID: 30878020
[TBL] [Abstract][Full Text] [Related]
29. Conditional mutations of beta-catenin and APC reveal roles for canonical Wnt signaling in lens differentiation.
Martinez G; Wijesinghe M; Turner K; Abud HE; Taketo MM; Noda T; Robinson ML; de Iongh RU
Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4794-806. PubMed ID: 19515997
[TBL] [Abstract][Full Text] [Related]
30. Identification of DNA-dependent protein kinase catalytic subunit as a novel interaction partner of lymphocyte enhancer factor 1.
Shimomura A; Takasaki A; Nomura R; Hayashi N; Senda T
Med Mol Morphol; 2013 Mar; 46(1):14-9. PubMed ID: 23325550
[TBL] [Abstract][Full Text] [Related]
31. Prognostic evidence of LEF1 isoforms in childhood acute lymphoblastic leukemia.
Erbilgin Y; Hatirnaz Ng O; Can I; Firtina S; Kucukcankurt F; Karaman S; Karakas Z; Celkan TT; Zengin E; Aylan Gelen S; Nihal Ozdemir G; Yildirmak Y; Dogru O; Tansel T; Khodzhaev K; Toluk O; Ozbek U; Sayitoglu M
Int J Lab Hematol; 2021 Oct; 43(5):1093-1103. PubMed ID: 33844466
[TBL] [Abstract][Full Text] [Related]
32. [Development of an ELISA-based high throughput screening method for novel anticancer agents targeting β-catenin/Lef1 interaction].
Chen Y; Niu X; Li Y; Liu X
Sheng Wu Gong Cheng Xue Bao; 2019 Apr; 35(4):707-717. PubMed ID: 31001956
[TBL] [Abstract][Full Text] [Related]
33. Expression of the lymphoid enhancer factor 1 is required for normal hematopoietic stem and progenitor cell function.
Edmaier KE; Stahnke K; Vegi N; Mulaw M; Ihme S; Scheffold A; Rudolph KL; Buske C
Leukemia; 2014 Jan; 28(1):227-30. PubMed ID: 23942465
[No Abstract] [Full Text] [Related]
34. Tcf1 and Lef1 pack their own HDAC.
Ng CP; Littman DR
Nat Immunol; 2016 May; 17(6):615-6. PubMed ID: 27196513
[TBL] [Abstract][Full Text] [Related]
35. Tales of the unexpected: Tcf1 functions as a tumor suppressor for leukemias.
Staal FJ; Clevers H
Immunity; 2012 Nov; 37(5):761-3. PubMed ID: 23159221
[TBL] [Abstract][Full Text] [Related]
36. [Cytological forms and prognostic aspects of acute leukemias].
LEVY JP
Cah Rmf Bull Med Guide Pract Rev; 1962 Mar; 76():187-8. PubMed ID: 14464780
[No Abstract] [Full Text] [Related]
37. Abstracts from Acute Leukemias XI. Prognostic Factors and Treatment Strategies. February 18-22, 2006. Munich, Germany.
Ann Hematol; 2006; 85 Suppl 1():12-126. PubMed ID: 16456698
[No Abstract] [Full Text] [Related]
38. Treatment and prognosis in the leukemias and allied disorders.
STURGIS CC
Postgrad Med; 1951 May; 9(5):375-82. PubMed ID: 14833946
[No Abstract] [Full Text] [Related]
39. [Expression and Clinical Significance of Lymphoid Enhancer-Binding Factor 1 in Acute Leukemias].
Huo WY; Gao J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Jun; 23(3):888-91. PubMed ID: 26117056
[TBL] [Abstract][Full Text] [Related]
40. Aberrant beta-catenin and LEF1 expression may predict the clinical outcome for patients with oropharyngeal cancer.
Papagerakis P; Pannone G; Shabana AH; Depondt J; Santoro A; Ghirtis K; Berdal A; Papagerakis S
Int J Immunopathol Pharmacol; 2012; 25(1):135-46. PubMed ID: 22507326
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
